Are the Newer Antidiabetic Agents Worth the Cost?
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2016-03-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/7384/17683_CE(RA1)_F(T)_PF1(Vi_Om)_PFA(AK)_PF2(PAG).pdf |
| _version_ | 1819063431866613760 |
|---|---|
| author | Sudhakar Pemminati Richard Mark Millis Ashwin Kamath Ashok Kudgi Shenoy Shivapraksh Gangachannaiah |
| author_facet | Sudhakar Pemminati Richard Mark Millis Ashwin Kamath Ashok Kudgi Shenoy Shivapraksh Gangachannaiah |
| author_sort | Sudhakar Pemminati |
| collection | DOAJ |
| first_indexed | 2024-12-21T15:14:34Z |
| format | Article |
| id | doaj.art-a7fae0e365544739a4977f6cad28a8e2 |
| institution | Directory Open Access Journal |
| issn | 2249-782X 0973-709X |
| language | English |
| last_indexed | 2024-12-21T15:14:34Z |
| publishDate | 2016-03-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj.art-a7fae0e365544739a4977f6cad28a8e22022-12-21T18:59:12ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-03-01103FL0110.7860/JCDR/2016/17683.7384Are the Newer Antidiabetic Agents Worth the Cost?Sudhakar Pemminati0Richard Mark Millis1Ashwin Kamath2Ashok Kudgi Shenoy3Shivapraksh Gangachannaiah4Associate Professor, Department of Pharmacology, AUA College of Medicine, Manipal University, Antigua.Professor, Department of Physiology, AUA College of Medicine, Antigua.Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore.Professor, Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore.Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal.https://jcdr.net/articles/PDF/7384/17683_CE(RA1)_F(T)_PF1(Vi_Om)_PFA(AK)_PF2(PAG).pdfantihyperglycemic agentsdpp-4 inhibitorssglt-2 inhibitors |
| spellingShingle | Sudhakar Pemminati Richard Mark Millis Ashwin Kamath Ashok Kudgi Shenoy Shivapraksh Gangachannaiah Are the Newer Antidiabetic Agents Worth the Cost? Journal of Clinical and Diagnostic Research antihyperglycemic agents dpp-4 inhibitors sglt-2 inhibitors |
| title | Are the Newer Antidiabetic Agents Worth the Cost? |
| title_full | Are the Newer Antidiabetic Agents Worth the Cost? |
| title_fullStr | Are the Newer Antidiabetic Agents Worth the Cost? |
| title_full_unstemmed | Are the Newer Antidiabetic Agents Worth the Cost? |
| title_short | Are the Newer Antidiabetic Agents Worth the Cost? |
| title_sort | are the newer antidiabetic agents worth the cost |
| topic | antihyperglycemic agents dpp-4 inhibitors sglt-2 inhibitors |
| url | https://jcdr.net/articles/PDF/7384/17683_CE(RA1)_F(T)_PF1(Vi_Om)_PFA(AK)_PF2(PAG).pdf |
| work_keys_str_mv | AT sudhakarpemminati arethenewerantidiabeticagentsworththecost AT richardmarkmillis arethenewerantidiabeticagentsworththecost AT ashwinkamath arethenewerantidiabeticagentsworththecost AT ashokkudgishenoy arethenewerantidiabeticagentsworththecost AT shivaprakshgangachannaiah arethenewerantidiabeticagentsworththecost |